n-acetylneuraminic acid has been researched along with Viremia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Amorim, MJ; Gomes, C; Reis, CA; Santos, NB; Vaz da Silva, ZE | 1 |
1 other study(ies) available for n-acetylneuraminic acid and Viremia
Article | Year |
---|---|
Complement Decay-Accelerating Factor is a modulator of influenza A virus lung immunopathology.
Topics: Animals; Bronchoalveolar Lavage Fluid; CD55 Antigens; Chemotaxis, Leukocyte; Complement Activation; Hemagglutinin Glycoproteins, Influenza Virus; Host Adaptation; Host Specificity; Host-Pathogen Interactions; Influenza A Virus, H1N1 Subtype; Interferon-gamma; Lung; Mice; Mice, Inbred C57BL; N-Acetylneuraminic Acid; Neuraminidase; Orthomyxoviridae Infections; Viral Load; Viral Proteins; Viremia; Virulence; Virus Replication; Weight Loss | 2021 |